Showing results (1891-1900 of 2,519) with videos related to

Sort By:
Pageof 252
Diabetes, Obesity & Metabolism|April 28, 2026
Effects of Dapagliflozin on Cardiovascular Outcomes in Patients With Type 2 Diabetes at Risk of Liver FibrosisJan Oscarsson, Monika Huhn, Yunyun Jiang, et al.
Tumour Virus Research|February 3, 2023
Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screeningLouiza S Velentzis, David Hawkes, Michael Caruana, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2012
Dual blockade of lipid and cyclin-dependent kinases induces synthetic lethality in malignant gliomaChristine K Cheng, W Clay Gustafson, Elizabeth Charron, et al.
Journal of Lower Genital Tract Disease|December 20, 2024
How Does Transitioning to Primary Human Papillomavirus Screening Impact Colposcopy Services? Lessons From an Australian National ProgramChloe J Jennett, Megan A Smith, Dorothy A Machalek, et al.
Acta Crystallographica. Section D, Biological Crystallography|May 2, 2013
AutoDrug: fully automated macromolecular crystallography workflows for fragment-based drug discoveryYingssu Tsai, Scott E McPhillips, Ana González, et al.
BMC Cancer|June 13, 2021
Food and Drug Administration approvals in phase 3 Cancer clinical trialsJoseph Abi Jaoude, Ramez Kouzy, Marc Ghabach, et al.
ACS Chemical Biology|April 20, 2021
Ten-Year Retrospective of the Vanderbilt Institute of Chemical Biology Chemical Synthesis CoreKwangho Kim, Plamen P Christov, Ian Romaine, et al.
Head & Neck|August 3, 2023
Prevalence of pituitary hormone dysfunction following radiotherapy for sinonasal and nasopharyngeal malignanciesKevin J Contrera, Jack Phan, Steven G Waguespack, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 11, 2024
The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysisPhil McEwan, Peter D Gabb, Jason A Davis, et al.
The Lancet. Diabetes & Endocrinology|October 7, 2021
Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trialHiddo J L Heerspink, Niels Jongs, Glenn M Chertow, et al.
Pageof 252